Titan Biotech Share Price

  • 624.9015.10 (2.47%)
  • Volume: 875
BSE
  • Live
  • Last Updated On: 01 Jul, 2024, 09:27 AM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Titan Biotech Share Pri...

  • 624.9015.10 (2.47%)
  • Volume: 875
Advertisment

Titan Biotech share price insights

View All

  • Company's annual revenue growth of 13.62% outperformed its 3 year CAGR of 5.0%. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 75.61% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 14.45% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Titan Biotech Ltd. share price moved up by 2.47% from its previous close of Rs 609.80. Titan Biotech Ltd. stock last traded price is 624.90

    Share PriceValue
    Today/Current/Last-624.90
    Previous Day-609.80

InsightsTitan Biotech

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		20.94
    EPS - TTM
    (₹)    		30.07
    MCap
    (₹ Cr.)    		520.37
    Sectoral MCap Rank
    		89
    PB Ratio
    (x)    		3.79
    Div Yield
    (%)    		0.32
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.20
    3 Months-0.75
    6 Months-0.41
    1 Year0.16
    3 Years0.45

    		-0.20
    VWAP
    (₹)    		627.49
    52W H/L
    (₹)
    645.00 / 250.25

    Titan Biotech Share Price Returns

    1 Day2.47%
    1 Week8.67%
    1 Month15.52%
    3 Months17.22%
    1 Year136.48%
    3 Years77.35%
    5 Years1566.4%

    ET Stock ScreenersTop Score Companies

    Check whether Titan Biotech belongs to analysts' top-rated companies list?

    View Stock Screeners

    Titan Biotech News & Analysis

    View all Titan Biotech Share News & Announcements

    Titan Biotech Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Titan Biotech Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Titan Biotech Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 13.62% outperformed its 3 year CAGR of 5.0%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 14.45% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income40.4046.4243.9835.0337.33
      Total Income Growth (%)-12.975.5425.55-6.1621.94
      Total Expenses33.6836.2135.5727.6630.72
      Total Expenses Growth (%)-6.991.7928.63-9.9614.43
      EBIT6.7210.208.417.376.61
      EBIT Growth (%)-34.1921.3914.0011.4975.41
      Profit after Tax (PAT)5.007.176.526.164.95
      PAT Growth (%)-30.3610.025.8624.4351.80
      EBIT Margin (%)16.6221.9819.1121.0517.72
      Net Profit Margin (%)12.3715.4614.8317.5913.26
      Basic EPS (₹)5.868.687.897.476.07
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income40.4046.4243.9835.0337.33
      Total Income Growth (%)-12.975.5425.55-6.1621.94
      Total Expenses33.6836.2135.5727.6630.72
      Total Expenses Growth (%)-6.991.7928.63-9.9614.43
      EBIT6.7210.208.417.376.61
      EBIT Growth (%)-34.1921.3914.0011.4975.41
      Profit after Tax (PAT)4.847.386.035.414.64
      PAT Growth (%)-34.4322.4611.4616.4971.86
      EBIT Margin (%)16.6221.9819.1121.0517.72
      Net Profit Margin (%)11.9815.9113.7115.4412.44
      Basic EPS (₹)5.868.937.306.555.62
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue165.82145.94153.83143.0379.89
      Total Revenue Growth (%)13.62-5.137.5679.0321.79
      Total Expenses134.29117.83115.63100.0070.10
      Total Expenses Growth (%)13.971.9015.6442.6516.73
      Profit after Tax (PAT)24.8524.8428.7430.347.07
      PAT Growth (%)0.04-13.57-5.25329.33100.60
      Operating Profit Margin (%)19.9220.0425.8331.4215.26
      Net Profit Margin (%)15.1417.2518.8021.328.89
      Basic EPS (₹)28.6425.4430.6636.718.55
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue165.82145.94124.49123.1269.89
      Total Revenue Growth (%)13.6217.231.1176.1718.67
      Total Expenses134.29117.8395.5284.0362.26
      Total Expenses Growth (%)13.9723.3513.6734.9814.16
      Profit after Tax (PAT)23.6621.0221.6828.776.20
      PAT Growth (%)12.55-3.04-24.64363.97101.32
      Operating Profit Margin (%)19.9220.0424.0832.9513.71
      Net Profit Margin (%)14.4214.6017.5523.498.92
      Basic EPS (₹)28.6425.4426.2434.827.50

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets156.58134.52143.40100.7276.04
      Total Assets Growth (%)16.40-6.2042.3832.4517.47
      Total Liabilities23.1324.6037.9928.2434.49
      Total Liabilities Growth (%)-6.00-35.2334.51-18.1311.37
      Total Equity133.45109.91105.4172.4841.55
      Total Equity Growth (%)21.424.2745.4474.4523.07
      Current Ratio (x)3.773.363.623.102.16
      Total Debt to Equity (x)0.050.060.160.190.58
      Contingent Liabilities0.001.133.200.38-
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets151.57130.70107.5686.1765.20
      Total Assets Growth (%)15.9721.5124.8232.168.99
      Total Liabilities23.1324.6021.3220.3527.39
      Total Liabilities Growth (%)-5.9815.384.77-25.70-2.73
      Total Equity128.44106.0986.2465.8237.81
      Total Equity Growth (%)21.0723.0231.0274.0819.43
      Current Ratio (x)3.773.363.853.492.31
      Total Debt to Equity (x)0.060.070.070.110.45
      Contingent Liabilities0.001.133.200.77-

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 20.3 cr for investing activities which is an YoY decrease of 2.03%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities21.1521.1822.8619.246.12
      Net Cash used in Investing Activities-20.30-20.73-18.78-8.08-2.21
      Net Cash flow from Financing Activities-2.87-2.406.08-7.54-3.95
      Net Cash Flow-2.02-1.9510.163.62-0.04
      Closing Cash & Cash Equivalent2.844.8615.615.451.83
      Closing Cash & Cash Equivalent Growth (%)-41.61-68.84186.33197.41-2.25
      Total Debt/ CFO (x)0.340.330.690.683.74
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities21.1521.1821.9517.756.92
      Net Cash used in Investing Activities-20.30-20.73-16.44-4.33-0.94
      Net Cash flow from Financing Activities-2.87-2.40-4.01-9.81-5.87
      Net Cash Flow-2.02-1.951.513.610.11
      Closing Cash & Cash Equivalent2.844.866.815.311.70
      Closing Cash & Cash Equivalent Growth (%)-41.61-28.6228.36212.097.12
      Total Debt/ CFO (x)0.340.330.260.422.44

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)18.6222.6029.1344.1118.02
      Return on Capital Employed (%)23.7825.2833.4154.7721.80
      Return on Assets (%)15.8718.4620.0430.119.29
      Interest Coverage Ratio (x)30.7942.1832.7626.805.19
      Asset Turnover Ratio (x)1.131.041.19141.22104.46
      Price to Earnings (x)17.576.557.545.064.99
      Price to Book (x)3.271.482.192.230.90
      EV/EBITDA (x)12.235.245.323.514.21
      EBITDA Margin (%)21.9521.8427.4932.9817.53
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)18.4219.8125.1443.7116.40
      Return on Capital Employed (%)24.6826.1532.6456.2019.55
      Return on Assets (%)15.6116.0820.1533.399.51
      Interest Coverage Ratio (x)30.7942.1840.9831.655.01
      Asset Turnover Ratio (x)1.161.211.28142.11106.56
      Price to Earnings (x)18.457.749.995.335.69
      Price to Book (x)3.401.532.512.330.93
      EV/EBITDA (x)12.235.246.713.664.47
      EBITDA Margin (%)21.9521.8425.9934.6716.22

    Financial InsightsTitan Biotech

    • Income (P&L)
    • Cash Flow

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 13.62% outperformed its 3 year CAGR of 5.0%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 14.45% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 20.3 cr for investing activities which is an YoY decrease of 2.03%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Titan Biotech Peer Comparison

    • Titan Biotech Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 75.61% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 75.61% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Titan Biotech21.113.9318.6223.7815.875.0019.9214.4228.643.770.050.34
          Jayant Agro Org17.961.649.7113.276.049.373.842.5517.592.170.289.07
          Dharamsi Morarji68.183.775.5311.473.0717.449.453.534.651.080.311.70
          Sunshield Chem35.638.1722.9231.678.2212.5812.186.6425.620.881.042.03
          Shree Pushkar Chem17.101.347.829.685.2226.486.855.1011.721.800.236.66
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Aarti Surfactants
          • Dai Ichi Kark
          • Chemcrux Ent
          • Alkali Metals
          • Lasa Supergenerics

          Choose from Stocks

            See All Parameters

          Peers InsightsTitan Biotech

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 75.61% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Titan Biotech Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Titan Biotech Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters55.8855.8855.8855.88
            Pledge0.000.000.000.00
            FII0.000.000.000.00
            DII0.230.000.000.00
            Mutual Funds0.000.000.000.00
            Others43.8944.1244.1244.12
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters46,17,51555.88 %0.00
            Pledge00.00 %0.00
            DII18,7120.23 %-
            Others36,27,47343.89 %-0.22

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Titan Biotech News Titan Biotech Quarterly Results Titan Biotech Dividend Titan Biotech Q1 ResultsTitan Biotech Q2 ResultsTitan Biotech Q3 ResultsTitan Biotech Q4 Results

          Corporate Actions

          • Titan Biotech Board Meeting/AGM

          • Titan Biotech Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            May 29, 2024May 21, 2024Board MeetingAudited Results
            Feb 12, 2024Jan 31, 2024Board MeetingQuarterly Results
            Nov 08, 2023Oct 26, 2023Board MeetingQuarterly Results
            Sep 29, 2023Sep 06, 2023AGMRs.1.8000 per share(18%)Final Dividend & A.G.M.
            Aug 10, 2023Jul 31, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final18%1.8Sep 22, 2023Sep 06, 2023
            Final15%1.5Sep 22, 2022Jun 01, 2022
            Final15%1.5Sep 16, 2021Jul 01, 2021
            Final10%1.0Sep 17, 2020Jun 30, 2020
            Final20%2.0-May 29, 2024

          • No other corporate actions details are available.

          About Titan Biotech

          Titan Biotech Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 505.74 Crore) operating in Chemicals sector. Titan Biotech Ltd. key Products/Revenue Segments include Biological Product for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • NK

            Naresh Kumar Singla

            Managing Director
            SC

            Suresh Chand Singla

            Managing Director
            RS

            Raja Singla

            Whole Time Director
            AA

            Abhishek Agarwal

            Independent Director
            Show More
          • A N S K & Associates
            Sunita Agrawal & Co.

          Industry

          Chemicals - Others

          Key Indices Listed on

          -

          Address

          A - 902 A, RIICO Industrial Area,Phase - III,Bhiwadi, Rajasthan - 301019

          Contact

          [email protected]

          http://www.titanbiotechltd.com

          More Details

          FAQs about Titan Biotech share

          • 1. What's the Titan Biotech share price today?
            Titan Biotech share price was Rs 625.00 as on 01 Jul, 2024, 09:17 AM IST. Titan Biotech share price was up by 2.49% based on previous share price of Rs 618.75. Titan Biotech share price trend:
            • Last 1 Month: Titan Biotech share price moved up by 15.54%
            • Last 3 Months: Titan Biotech share price moved up by 17.24%
            • Last 12 Months: Titan Biotech share price moved up 136.52%
            • Last 3 Years: Titan Biotech Share price moved up by 77.38%
          • 2. What is the CAGR of Titan Biotech?
            The CAGR of Titan Biotech is 3.63.
          • 3. Who are the peers for Titan Biotech in Chemicals sector?
            Within Chemicals sector Titan Biotech, Aarti Surfactants Ltd., Dai Ichi Karkaria Ltd., Shree Pushkar Chemicals & Fertilisers Ltd., Chemcrux Enterprises Ltd., Sunshield Chemicals Ltd., DMCC Speciality Chemicals Ltd., Alkali Metals Ltd., Lasa Supergenerics Ltd., Hardcastle & Waud Manufacturing Company Ltd. and Jayant Agro Organics Ltd. are usually compared together by investors for analysis.
          • 4. What is the PE & PB ratio of Titan Biotech?
            The PE ratio of Titan Biotech stands at 20.35, while the PB ratio is 3.79.
          • 5. What dividend is Titan Biotech giving?
            Titan Biotech Ltd. announced an equity dividend of 18% on a face value of 10.0 amounting to Rs 1.8 per share on 06 Sep 2023. The ex dividend date was 22 Sep 2023.
          • 6. What are the returns for Titan Biotech share?
            Return Performance of Titan Biotech Shares:
            • 1 Week: Titan Biotech share price moved up by 8.69%
            • 1 Month: Titan Biotech share price moved up by 15.54%
            • 3 Month: Titan Biotech share price moved up by 17.24%
            • 6 Month: Titan Biotech share price moved up by 51.86%
          • 7. What are the key metrics to analyse Titan Biotech Share Price?
            Key Metrics for Titan Biotech are:
            • PE Ratio of Titan Biotech is 20.94
            • Price/Sales ratio of Titan Biotech is 2.66
            • Price to Book ratio of Titan Biotech is 3.79
          • 8. What are the Titan Biotech quarterly results?
            On Consoldiated basis, Titan Biotech reported a total income and loss of Rs 40.40 Cr and Rs 5.00 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 165.82 Cr and Rs 24.85 Cr.
          • 9. What is 52 week high/low of Titan Biotech share price?
            52 Week high of Titan Biotech share is Rs 645.00 while 52 week low is Rs 250.25
          • 10. What is the market cap of Titan Biotech?
            Market Capitalization of Titan Biotech stock is Rs 520.37 Cr.
          • 11. Who are the key owners of Titan Biotech stock?
              • Promoter holding has not changed in last 9 months and holds 55.88 stake as on 31 Mar 2024
              • Other investor holding have gone down from 44.12 (30 Jun 2023) to 43.89 (31 Mar 2024)

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Titan Biotech Share Price
          The Economic Times